Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 35.08 Million USD | 21.2% |
| 2022 | 25.71 Million USD | -1.89% |
| 2021 | 26.21 Million USD | 28.53% |
| 2020 | 20.39 Million USD | 7.16% |
| 2019 | 19.03 Million USD | 15.31% |
| 2018 | 16.5 Million USD | 25.18% |
| 2017 | 13.18 Million USD | 92.11% |
| 2016 | 6.86 Million USD | 19.13% |
| 2015 | 5.76 Million USD | 3.83% |
| 2014 | 5.54 Million USD | 19.93% |
| 2013 | 4.62 Million USD | 25.44% |
| 2012 | 3.68 Million USD | -18.39% |
| 2011 | 4.51 Million USD | 17.35% |
| 2010 | 3.85 Million USD | 27.3% |
| 2009 | 3.02 Million USD | 12130.27% |
| 2008 | 24.73 Thousand USD | -27.33% |
| 2007 | 34.03 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 10.11 Million USD | 7.13% |
| 2024 Q2 | 9.74 Million USD | -3.68% |
| 2023 FY | 31.16 Million USD | 21.2% |
| 2023 Q2 | 8.53 Million USD | 1.11% |
| 2023 Q3 | 7.67 Million USD | -10.11% |
| 2023 Q4 | 9.44 Million USD | 23.07% |
| 2023 Q1 | 8.44 Million USD | 4.65% |
| 2022 Q4 | 8.06 Million USD | 23.61% |
| 2022 Q3 | 6.52 Million USD | -7.83% |
| 2022 FY | 25.71 Million USD | -1.89% |
| 2022 Q1 | 6.85 Million USD | -13.5% |
| 2022 Q2 | 7.08 Million USD | 3.4% |
| 2021 Q2 | 6.39 Million USD | 8.85% |
| 2021 Q1 | 5.87 Million USD | -9.2% |
| 2021 Q4 | 7.91 Million USD | 31.52% |
| 2021 FY | 26.21 Million USD | 28.53% |
| 2021 Q3 | 6.02 Million USD | -5.86% |
| 2020 Q3 | 4.9 Million USD | 29.54% |
| 2020 FY | 20.39 Million USD | 7.16% |
| 2020 Q2 | 3.78 Million USD | -27.44% |
| 2020 Q4 | 6.47 Million USD | 31.81% |
| 2020 Q1 | 5.22 Million USD | -14.69% |
| 2019 Q4 | 6.12 Million USD | 28.84% |
| 2019 Q1 | 3.97 Million USD | -13.09% |
| 2019 FY | 19.03 Million USD | 15.31% |
| 2019 Q2 | 4.18 Million USD | 5.15% |
| 2019 Q3 | 4.75 Million USD | 13.65% |
| 2018 Q1 | 3.93 Million USD | 0.56% |
| 2018 FY | 16.5 Million USD | 25.18% |
| 2018 Q4 | 4.57 Million USD | 18.8% |
| 2018 Q3 | 3.85 Million USD | -6.97% |
| 2018 Q2 | 4.13 Million USD | 5.1% |
| 2017 Q2 | 3.38 Million USD | 51.71% |
| 2017 Q1 | 2.23 Million USD | -9.84% |
| 2017 FY | 13.18 Million USD | 92.11% |
| 2017 Q4 | 3.91 Million USD | 7.61% |
| 2017 Q3 | 3.63 Million USD | 7.39% |
| 2016 Q4 | 2.47 Million USD | 57.0% |
| 2016 Q2 | 1.51 Million USD | 17.04% |
| 2016 FY | 6.86 Million USD | 19.13% |
| 2016 Q3 | 1.57 Million USD | 4.3% |
| 2016 Q1 | 1.29 Million USD | -22.44% |
| 2015 FY | 5.76 Million USD | 3.83% |
| 2015 Q4 | 1.66 Million USD | 25.87% |
| 2015 Q3 | 1.32 Million USD | -8.85% |
| 2015 Q2 | 1.45 Million USD | 10.43% |
| 2015 Q1 | 1.31 Million USD | -20.06% |
| 2014 Q1 | 1.21 Million USD | -18.64% |
| 2014 Q2 | 1.43 Million USD | 18.3% |
| 2014 Q3 | 1.24 Million USD | -13.47% |
| 2014 Q4 | 1.64 Million USD | 32.15% |
| 2014 FY | 5.54 Million USD | 19.93% |
| 2013 Q1 | 1.07 Million USD | -9.26% |
| 2013 Q2 | 1.07 Million USD | -0.15% |
| 2013 Q3 | 984.42 Thousand USD | -8.18% |
| 2013 Q4 | 1.49 Million USD | 51.94% |
| 2013 FY | 4.62 Million USD | 25.44% |
| 2012 Q4 | 1.18 Million USD | 30.65% |
| 2012 FY | 3.68 Million USD | -18.39% |
| 2012 Q2 | 644.78 Thousand USD | -32.41% |
| 2012 Q1 | 953.9 Thousand USD | -27.09% |
| 2012 Q3 | 905.73 Thousand USD | 40.47% |
| 2011 FY | 4.51 Million USD | 17.35% |
| 2011 Q4 | 1.3 Million USD | 13.06% |
| 2011 Q2 | 1.17 Million USD | 33.2% |
| 2011 Q1 | 880.53 Thousand USD | -19.12% |
| 2011 Q3 | 1.15 Million USD | -1.34% |
| 2010 Q4 | 1.08 Million USD | 4.42% |
| 2010 FY | 3.85 Million USD | 27.3% |
| 2010 Q2 | 1 Million USD | 42.12% |
| 2010 Q3 | 1.04 Million USD | 3.29% |
| 2010 Q1 | 710.2 Thousand USD | -4.51% |
| 2009 Q2 | 614.65 Thousand USD | 112447.46% |
| 2009 FY | 3.02 Million USD | 12130.27% |
| 2009 Q4 | 743.71 Thousand USD | -23.33% |
| 2009 Q3 | 969.97 Thousand USD | 57.81% |
| 2009 Q1 | 546.13 USD | -76.64% |
| 2008 FY | 24.73 Thousand USD | -27.33% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 10.95 Thousand USD | -42.96% |
| 2008 Q3 | 5609.21 USD | 0.0% |
| 2008 Q4 | 2337.85 USD | -58.32% |
| 2007 FY | 34.03 Thousand USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | 12.96 Thousand USD | 0.0% |
| 2007 Q4 | 19.19 Thousand USD | 48.13% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -7422.364% |
| IR-Med Inc. | -17 Thousand USD | 206472.947% |
| Polarean Imaging plc | 335.48 Thousand USD | -10357.579% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -1894.873% |
| Avitar, Inc. | 836.7 Thousand USD | -4093.058% |
| AVITA Medical, Inc. | 41.68 Million USD | 15.842% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 3508440.1% |
| Össur hf. | 485.57 Million USD | 92.775% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 18061.92% |
| QHSLab, Inc. | 793.6 Thousand USD | -4320.752% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 92.775% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -109.525% |
| Escalon Medical Corp. | 5.14 Million USD | -581.735% |
| Aurora Spine Corporation | 8.21 Million USD | -327.258% |
| BrainsWay Ltd. | 23.09 Million USD | -51.935% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -33280.019% |
| Vivos Inc. | -6036.00 USD | 581335.934% |
| MicroPort Scientific Corporation | 532.09 Million USD | 93.407% |
| Kelyniam Global, Inc. | 2.03 Million USD | -1623.087% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 4736.13% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -61891.379% |
| Nanomix Corporation | -69.45 Thousand USD | 50610.238% |
| Theraclion SA | -1.08 Million USD | 3347.305% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -5871.135% |
| Positron Corporation | -353.46 Thousand USD | 10025.566% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -3255.642% |
| Lombard Medical, Inc. | 955 Thousand USD | -3573.655% |
| ALR Technologies Inc. | 4945.00 USD | -709372.214% |
| Stratec SE | 71.58 Million USD | 50.993% |
| Vycor Medical, Inc. | 1.31 Million USD | -2566.613% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 272064.349% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -16896.207% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -144.262% |
| VMS Rehab Systems, Inc. | -10.44 USD | 336048002.299% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -97353.892% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -12962.649% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 438642.513% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -3106.754% |
| Urologix, Inc. | 6.09 Million USD | -475.798% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 11178.117% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -4817.45% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.103% |
| NIOX Group Plc | 28.13 Million USD | -24.704% |
| Fuse Medical, Inc. | 10.73 Million USD | -226.849% |
| Broncus Holding Corporation | 7.22 Million USD | -385.449% |
| Brain Scientific Inc. | 54.32 Thousand USD | -64480.582% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -4287.827% |
| Health Logic Interactive Inc. | - USD | -Infinity% |